|
1
|
Baumgart DC and Carding SR: Inflammatory
bowel disease: Cause and immunobiology. Lancet. 369:1627–1640.
2007. View Article : Google Scholar
|
|
2
|
Bouma G and Strober W: The immunological
and genetic basis of inflammatory bowel disease. Nat Rev Immunol.
3:521–533. 2003. View
Article : Google Scholar
|
|
3
|
Greuter T and Vavricka SR: Extraintestinal
manifestations in inflammatory bowel disease-epidemiology,
genetics, and pathogenesis. Expert Rev Gastroenterol Hepatol.
13:307–317. 2019. View Article : Google Scholar
|
|
4
|
Bonen DK and Cho JH: The genetics of
inflammatory bowel disease. Gastroenterology. 124:521–536. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Flannigan KL, Geem D, Harusato A and
Denning TL: Intestinal antigen-presenting cells: Key regulators of
immune homeostasis and inflammation. Am J Pathol. 185:1809–1819.
2015. View Article : Google Scholar
|
|
6
|
Kmieć Z, Cyman M and Ślebioda TJ: Cells of
the innate and adaptive immunity and their interactions in
inflammatory bowel disease. Adv Med Sci. 62:1–16. 2017. View Article : Google Scholar
|
|
7
|
Spencer EA and Dubinsky MC: Therapeutic
drug monitoring in inflammatory bowel disease: History and future
directions. Pediatr Clin North Am. 64:1309–1326. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dulai PS and Jairath V: Acute severe
ulcerative colitis: Latest evidence and therapeutic implications.
Ther Adv Chronic Dis. 9:65–72. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chiu CY, Gomolka B, Dierkes C, Huang NR,
Schroeder M, Purschke M, Manstein D, Dangi B and Weylandt KH:
Omega-6 docosapentaenoic acid-derived resolvins and
17-hydroxydocosahexaenoic acid modulate macrophage function and
alleviate experimental colitis. Inflamm Res. 61:967–976. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Arita M, Bianchini F, Aliberti J, Sher A,
Chiang N, Hong S, Yang R, Petasis NA and Serhan CN: Stereochemical
assignment, antiinflammatory properties, and receptor for the
omega-3 lipid mediator resolvin E1. J Exp Med. 201:713–722. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bento AF, Claudino RF, Dutra RC, Marcon R
and Calixto JB: Omega-3 fatty acid-derived mediators 17(R)-hydroxy
docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2
prevent experimental colitis in mice. J Immunol. 187:1957–1969.
2011. View Article : Google Scholar
|
|
12
|
Gobbetti T, Dalli J, Colas RA, Federici
Canova DF, Aursnes M, Bonnet D, Alric L, Vergnolle N, Deraison C,
Hansen TV, et al: Protectin D1n-3 DPA and resolvin
D5n-3 DPA are effectors of intestinal protection. Proc
Natl Acad Sci USA. 114:3963–3968. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yi JJ, Heo SY, Ju JH, Oh BR, Son WS and
Seo JW: Synthesis of two new lipid mediators from docosahexaenoic
acid by combinatorial catalysis involving enzymatic and chemical
reaction. Sci Rep. 10:188492020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang L, Choi HS, Su Y, Lee B, Song JJ,
Jang YS and Seo JW: 7S,15R-Dihydroxy-16S,17S-Epoxy-Docosapentaenoic
Acid, a Novel DHA Epoxy Derivative, Inhibits Colorectal Cancer
Stemness through Repolarization of Tumor-Associated Macrophage
Functions and the ROS/STAT3 Signaling Pathway. Antioxidants
(Basel). 10:14592021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Serhan CN, Chiang N, Dalli J and Levy BD:
Lipid mediators in the resolution of inflammation. Cold Spring Harb
Perspect Biol. 7:a0163112014. View Article : Google Scholar
|
|
16
|
Spite M, Norling LV, Summers L, Yang R,
Cooper D, Petasis NA, Flower RJ, Perretti M and Serhan CN: Resolvin
D2 is a potent regulator of leukocytes and controls microbial
sepsis. Nature. 461:1287–1291. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wirtz S, Neufert C, Weigmann B and Neurath
MF: Chemically induced mouse models of intestinal inflammation. Nat
Protoc. 2:541–546. 2007. View Article : Google Scholar
|
|
18
|
Rumi G, Tsubouchi R, Okayama M, Kato S,
Mózsik G and Takeuchi K: Protective effect of lactulose on dextran
sulfate sodium-induced colonic inflammation in rats. Dig Dis Sci.
49:1466–1472. 2004. View Article : Google Scholar
|
|
19
|
Schmid M, Gemperle C, Rimann N and
Hersberger M: Resolvin D1 polarizes primary human macrophages
toward a proresolution phenotype through GPR32. J Immunol.
196:3429–3437. 2016. View Article : Google Scholar
|
|
20
|
Seong MA, Woo JK, Kang JH, Jang YS, Choi
S, Jang YS, Lee TH, Jung KH, Kang DK, Hurh BS, et al: Oral
administration of fermented wild ginseng ameliorates DSS-induced
acute colitis by inhibiting NF-κB signaling and protects intestinal
epithelial barrier. BMB Rep. 48:419–425. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Peterson LW and Artis D: Intestinal
epithelial cells: Regulators of barrier function and immune
homeostasis. Nat Rev Immunol. 14:141–153. 2014. View Article : Google Scholar
|
